Lördag 21 December | 19:57:43 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2025-10-30 07:30 Kvartalsrapport 2025-Q3
2025-07-18 07:30 Kvartalsrapport 2025-Q2
2025-04-29 07:30 Kvartalsrapport 2025-Q1
2025-04-02 N/A Årsstämma
2025-03-04 07:30 Bokslutskommuniké 2024
2024-10-30 - Kvartalsrapport 2024-Q3
2024-07-18 - Kvartalsrapport 2024-Q2
2024-04-25 - Kvartalsrapport 2024-Q1
2024-03-20 - X-dag ordinarie utdelning OKDAV 0.07 EUR
2024-03-20 - X-dag ordinarie utdelning OKDBV 0.07 EUR
2024-03-19 - Årsstämma
2024-02-16 - Bokslutskommuniké 2023
2023-10-31 - Kvartalsrapport 2023-Q3
2023-07-21 - Kvartalsrapport 2023-Q2
2023-04-27 - Kvartalsrapport 2023-Q1
2023-03-22 - X-dag ordinarie utdelning OKDAV 0.06 EUR
2023-03-22 - X-dag ordinarie utdelning OKDBV 0.06 EUR
2023-03-21 - Årsstämma
2023-02-16 - Bokslutskommuniké 2022
2022-10-27 - Kvartalsrapport 2022-Q3
2022-07-22 - Kvartalsrapport 2022-Q2
2022-04-28 - Kvartalsrapport 2022-Q1
2022-03-16 - X-dag ordinarie utdelning OKDAV 0.04 EUR
2022-03-16 - X-dag ordinarie utdelning OKDBV 0.04 EUR
2022-03-15 - Årsstämma
2022-02-18 - Bokslutskommuniké 2021
2021-10-27 - Kvartalsrapport 2021-Q3
2021-07-20 - Kvartalsrapport 2021-Q2
2021-04-27 - Kvartalsrapport 2021-Q1
2021-03-17 - X-dag ordinarie utdelning OKDAV 0.03 EUR
2021-03-17 - X-dag ordinarie utdelning OKDBV 0.03 EUR
2021-03-16 - Årsstämma
2021-02-18 - Bokslutskommuniké 2020
2020-10-23 - Kvartalsrapport 2020-Q3
2020-07-17 - Kvartalsrapport 2020-Q2
2020-04-24 - Kvartalsrapport 2020-Q1
2020-03-18 - X-dag ordinarie utdelning OKDAV 0.09 EUR
2020-03-18 - X-dag ordinarie utdelning OKDBV 0.09 EUR
2020-03-17 - Årsstämma
2020-02-07 - Bokslutskommuniké 2019
2019-07-17 - Kvartalsrapport 2019-Q2
2019-03-20 - X-dag ordinarie utdelning OKDAV 0.09 EUR
2019-03-20 - X-dag ordinarie utdelning OKDBV 0.09 EUR
2019-03-19 - Årsstämma
2018-11-01 - Kvartalsrapport 2018-Q3
2018-07-18 - Kvartalsrapport 2018-Q2
2018-04-27 - Kvartalsrapport 2018-Q1
2018-03-20 - X-dag ordinarie utdelning OKDAV 0.09 EUR
2018-03-20 - X-dag ordinarie utdelning OKDBV 0.09 EUR
2018-03-19 - Årsstämma
2018-02-13 - Bokslutskommuniké 2017
2017-10-25 - Kvartalsrapport 2017-Q3
2017-07-21 - Kvartalsrapport 2017-Q2
2017-04-28 - Kvartalsrapport 2017-Q1
2017-03-15 - X-dag ordinarie utdelning OKDAV 0.14 EUR
2017-03-15 - X-dag ordinarie utdelning OKDBV 0.14 EUR
2017-03-14 - Årsstämma
2017-02-13 - Bokslutskommuniké 2016
2016-10-20 - Kvartalsrapport 2016-Q3
2016-07-19 - Kvartalsrapport 2016-Q2
2016-04-22 - Kvartalsrapport 2016-Q1
2016-03-15 - X-dag ordinarie utdelning OKDAV 0.13 EUR
2016-03-15 - X-dag ordinarie utdelning OKDBV 0.13 EUR
2016-03-14 - Årsstämma
2016-02-05 - Bokslutskommuniké 2015
2015-10-22 - Kvartalsrapport 2015-Q3
2015-09-09 - Kapitalmarknadsdag 2015
2015-07-17 - Kvartalsrapport 2015-Q2
2015-04-23 - Kvartalsrapport 2015-Q1
2015-03-31 - X-dag ordinarie utdelning OKDAV 0.00 EUR
2015-03-31 - X-dag ordinarie utdelning OKDBV 0.00 EUR
2015-03-30 - Årsstämma
2015-02-06 - Bokslutskommuniké 2014
2014-10-23 - Kvartalsrapport 2014-Q3
2014-07-24 - Kvartalsrapport 2014-Q2
2014-04-24 - Kvartalsrapport 2014-Q1
2014-03-25 - X-dag ordinarie utdelning OKDAV 0.00 EUR
2014-03-25 - X-dag ordinarie utdelning OKDBV 0.00 EUR
2014-03-24 - Årsstämma
2014-02-07 - Bokslutskommuniké 2013
2013-10-24 - Kvartalsrapport 2013-Q3
2013-07-25 - Kvartalsrapport 2013-Q2
2013-04-25 - Kvartalsrapport 2013-Q1
2013-03-21 - X-dag ordinarie utdelning OKDAV 0.09 EUR
2013-03-21 - X-dag ordinarie utdelning OKDBV 0.09 EUR
2013-03-20 - Årsstämma
2013-02-07 - Bokslutskommuniké 2012
2012-10-25 - Kvartalsrapport 2012-Q3
2012-07-26 - Kvartalsrapport 2012-Q2
2012-04-26 - Kvartalsrapport 2012-Q1
2012-03-27 - X-dag ordinarie utdelning OKDAV 0.08 EUR
2012-03-27 - X-dag ordinarie utdelning OKDBV 0.08 EUR
2012-03-26 - Årsstämma
2012-02-09 - Bokslutskommuniké 2011
2011-10-27 - Kvartalsrapport 2011-Q3
2011-08-04 - Kvartalsrapport 2011-Q2
2011-04-28 - Kvartalsrapport 2011-Q1
2011-04-07 - X-dag ordinarie utdelning OKDAV 0.05 EUR
2011-04-07 - X-dag bonusutdelning OKDAV 0.13
2011-04-07 - X-dag ordinarie utdelning OKDBV 0.05 EUR
2011-04-07 - X-dag bonusutdelning OKDBV 0.13
2011-03-07 - Bokslutskommuniké 2010
2010-04-08 - X-dag ordinarie utdelning OKDAV 0.12 EUR
2010-04-08 - X-dag ordinarie utdelning OKDBV 0.12 EUR
2010-04-07 - Årsstämma
2010-02-11 - Bokslutskommuniké 2009
2009-04-17 - X-dag ordinarie utdelning OKDAV 0.08 EUR
2009-04-17 - X-dag ordinarie utdelning OKDBV 0.08 EUR
2008-03-18 - X-dag ordinarie utdelning OKDAV 0.08 EUR
2008-03-18 - X-dag ordinarie utdelning OKDBV 0.08 EUR
2007-03-14 - X-dag ordinarie utdelning OKDAV 0.06 EUR
2007-03-14 - X-dag ordinarie utdelning OKDBV 0.06 EUR

Beskrivning

LandFinland
ListaMid Cap Helsinki
SektorHälsovård
IndustriLäkemedel & Handel
Oriola är en läkemedelskoncern med särskilt fokus inom distribution av läkemedel till andra aktörer inom branschen. Bolaget erbjuder tjänster till apotek och övriga läkemedelsbolag, vilket exempelvis innefattar förhandlingar med leverantörer och distribution av produkter. Idag innehas störst verksamhet inom Norden och Baltikum. Huvudkontoret ligger i Esbo.
2024-12-11 08:15:00

Oriola Corporation  Stock Exchange Release  11 December 2024 at 9:15 a.m. EET

Oriola renews operating model and management team to accelerate strategy execution

Oriola plans to renew its operating model to accelerate its strategy execution, enhance the company's growth opportunities and to improve the value creation of its business. Accordingly, Oriola also makes changes to its Management Team.

The planned operating model consists of a common sales organisation and two commercial units, Services and Products, and Advisory Services. These will be supported by the Supply Chain unit and the enabling functions Finance, Digital, Legal, and People and Culture.The planned changes will not impact Oriola's external financial reporting segments.

"Oriola has delivered a solid performance during 2024, supported by our refined strategy, increased sales, and improved profitability. As we continue our journey to become the leading specialist in the wholesale of pharmaceuticals and health products, our planned operating model aims to enhance customer focus and sales growth. This model is also designed to accelerate efficiency and profitability improvement, speed up decision-making and strengthen our competitiveness in a rapidly changing business environment.  As one team we will generate the best possible value to our customers, shareholders and the society at large," comments Oriola's CEO Katarina Gabrielson.

Oriola's Management Team as of 1 January 2025

The planned operating model brings changes to the composition and responsibilities of Oriola's Management Team with the aim to enhance business acumen. Satu Nylén and Katja Lundell are appointed to Oriola's Management Team. Their CV's are presented at the end of this release. The recruitment for Executive Vice President, Sales is ongoing.

Satu Nylén, currently Service and Product Excellence Director, is appointed as Executive Vice President, Services and Products, and member of Oriola's Management Team as of 1 January 2025. Nylén joined Oriola in 2019 and has since then held various leadership roles in product sourcing, category management and business development. Nylén has extensive experience in retail, fast-moving consumer goods (FMCG) and change management.  

Katja Lundell, currently VP, Advisory Services, is appointed as Executive Vice President, Advisory Services, and member of Oriola's Management Team as of 1 January 2025. Lundell joined Oriola in September 2024 as Advisory Director. Lundell has more than 20 years of sales and marketing experience from the pharmaceutical sector with extensive knowledge of market access, regulatory and sales operations in the Nordic, European, UK and US markets.

"I warmly welcome Satu and Katja to our management team. Satu has extensive commercial and retail experience, and has worked with our sales and marketing teams both in Finland and Sweden. Katja has vast experience from the pharmaceutical sector and a strong network to support growing the advisory business. These two commercial appointments and the creation of a new common sales organisation underpins our enhanced focus on commercial excellence," Gabrielson continues.

Effective 1 January 2025, Oriola's Management Team consists of the following members:

  • Katarina Gabrielson, CEO
  • Mats Danielsson, CFO
  • Katarina Gabrielson (interim) EVP, Sales (recruitment ongoing)
  • Niklas Lindholm, Chief People Officer
  • Katja Lundell, EVP, Advisory Services
  • Mikael Nurmi, Chief Digital Officer
  • Satu Nylén, EVP, Services and Products
  • Petter Sandström, General Counsel
  • Tuomas Tiilikainen, Chief Supply Chain Officer (joins the company latest in April 2025)

Oriola's planned operating model

The planned operating model consists of a common sales organisation and two commercial units: Products and Services, and Advisory Services.

With the planned Sales unit, Oriola is creating stronger partnerships with improved customer focus, as well as reduced complexity for customers. This will give Oriola even more flexibility to respond to customer needs, and to better capture growth opportunities.

With the planned new commercial unit Services and Products, Oriola is enhancing an integrated service offering with a service and product portfolio that meets the standards of modern wholesale and e-commerce of pharmaceuticals and health products.

The existing commercial unit Advisory Services, will continue to support pharmaceutical companies and pharmacies to succeed in the Nordic countries by providing high-quality expert services and tailored commercial data solutions covering the entire lifespan of a pharmaceutical product.

The planned operating model also includes the existing Supply Chain unit and enabling functions Finance, Digital, Legal, and People and Culture.

The planned operating model is expected to be valid latest by the end of the first quarter 2025.

****
CV - Satu Nylén
Born 1965
M. Sc. (Economics)
Finnish citizen

Primary career
2019-present, Oriola, Service and Product Excellence Director
2017-2018, various business development and management consulting roles for retail and consumer goods
2003-2016, Stockmann, Merchandise Director, Retail and several executive roles building category portfolios and partnerships
1995-2000, Nordic Cosmetics, Managing Director
1993-1994, Hackmann Havi, Marketing Manager
1990-1992, Tamro Finland, Product Manager, Consumer goods

CV - Katja Lundell
Born 1974
M. Sc. (Economics)
Finnish and British citizen

Primary career
2024-present, Oriola, Advisory Director
2022-2024, Theramex, Senior Global Director, Head of Pricing, Access and Communications, UK
2021-2022, Paion AG, Vice President, Country General Manager, UK
2015-2019, Glenmark Pharmaceuticals, General Manager, UK and Nordics
2008-2015, Abbott, various leadership positions in business management, sales and marketing, Nordics and UK & Ireland
2008-2008, 7.4 Limited, Marketing strategy consultant, UK
2001-2008, Merck, Sharp & Dohme, various roles in product management, sales and marketing, Finland and the USA
*****

Further information:
Katarina Gabrielson, CEO
tel. +46 72 234 8809
email: katarina.gabrielson@oriola.com

Mikael Wegmüller
VP, Communications and Sustainability
tel. +356 40 7762 314
email: mikael.wegmuller@oriola.com

Distribution:
Nasdaq Helsinki Ltd.
Key media